Paranjpe Madhav G, Belich Jessica L, Mann Peter C, McKeon Marie E, Elbekai Reem H, Brown Caren M, Patrick Daniel J
1 MPI Research (a Charles River Company), Mattawan, Michigan, USA.
2 MilliporeSigma BioReliance® Toxicology Services, Rockville, Maryland, USA.
Toxicol Pathol. 2019 Jan;47(1):18-25. doi: 10.1177/0192623318810202. Epub 2018 Nov 8.
This article presents the historical control data of spontaneous tumors in Tg.rasH2 published in 2013 (2004-2012) and compares and contrasts it to more recent data collected from 2013 to 2018, reporting differences in the average percentage incidences or incidence ranges as well as the incidence of new tumors. In 2013, we published a comprehensive review of spontaneous tumors in Tg.rasH2 mice used in 26-week carcinogenicity studies, which included data from control dose groups from 26 studies and a total of 710 mice per sex. The total database, now including the more recent data, has nearly doubled the number of animals, completing to date a total of 52 studies in males and 51 studies in females for a total of 1,615 male mice and 1,560 female mice, respectively. In this article, we compare the data collected from 2004 to 2012 against the data collected from 2013 to 2018 and the overall tumor incidence change.
本文展示了2013年发表的Tg.rasH2自发肿瘤的历史对照数据(2004 - 2012年),并将其与2013年至2018年收集的最新数据进行比较和对比,报告平均发病率百分比或发病率范围以及新肿瘤发病率的差异。2013年,我们发表了一篇关于用于26周致癌性研究的Tg.rasH2小鼠自发肿瘤的全面综述,其中包括来自26项研究的对照剂量组数据,每种性别共有710只小鼠。目前的总数据库,包括了最新数据,动物数量几乎增加了一倍,截至目前,雄性共完成了52项研究,雌性共完成了51项研究,分别为1615只雄性小鼠和1560只雌性小鼠。在本文中,我们将2004年至2012年收集的数据与2013年至2018年收集的数据以及总体肿瘤发病率变化进行比较。